Caricamento...
Hepatitis C Vaccines, Antibodies, and T Cells
The development of vaccines that protect against persistent hepatitis C virus (HCV) infection remain a public health priority. The broad use of highly effective direct-acting antivirals (DAAs) is unlikely to achieve HCV elimination without vaccines that can limit viral transmission. Two vaccines tar...
Salvato in:
| Pubblicato in: | Front Immunol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6031729/ https://ncbi.nlm.nih.gov/pubmed/30002657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01480 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|